Business Description
Resverlogix Corp
NAICS : 325414
SIC : 3741
ISIN : CA76128M1086
Compare
Compare
Traded in other countries / regions
RVX.CanadaRVXCF.USARFS.Germany0VF9.UK IPO Date
2005-01-17Description
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -11.42 | |||||
| Debt-to-Equity | -0.09 | |||||
| Debt-to-EBITDA | -0.7 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 29.8 | |||||
| 3-Year FCF Growth Rate | 49 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.19 | |||||
| 9-Day RSI | 44.6 | |||||
| 14-Day RSI | 44.89 | |||||
| 6-1 Month Momentum % | -14.29 | |||||
| 12-1 Month Momentum % | -63.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.02 | |||||
| Quick Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.8 | |||||
| Shareholder Yield % | -3.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -152.24 | |||||
| ROIC % | -35.62 | |||||
| ROC (Joel Greenblatt) % | -3240.14 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.81 | |||||
| EV-to-EBITDA | -1.89 | |||||
| EV-to-FCF | -5.88 | |||||
| Earnings Yield (Greenblatt) % | -55.3 | |||||
| FCF Yield % | -27.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Resverlogix Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.053 | ||
| Beta | 1.42 | ||
| Volatility % | 56.36 | ||
| 14-Day RSI | 44.89 | ||
| 14-Day ATR (C$) | 0.003201 | ||
| 20-Day SMA (C$) | 0.05575 | ||
| 12-1 Month Momentum % | -63.64 | ||
| 52-Week Range (C$) | 0.05 - 0.16 | ||
| Shares Outstanding (Mil) | 274.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Resverlogix Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Resverlogix Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Resverlogix Corp Frequently Asked Questions
What is Resverlogix Corp(TSX:RVX)'s stock price today?
The current price of TSX:RVX is C$0.06. The 52 week high of TSX:RVX is C$0.16 and 52 week low is C$0.05.
When is next earnings date of Resverlogix Corp(TSX:RVX)?
The next earnings date of Resverlogix Corp(TSX:RVX) is 2024-05-10 Est..
Does Resverlogix Corp(TSX:RVX) pay dividends? If so, how much?
Resverlogix Corp(TSX:RVX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers